Physician

David J Ridley, M.D.

According to 2025 Medicare claims, David Ridley, M.D. (NPI: 1659396000) practices rheumatology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Ramsey, MN. This provider's primary affiliated billing organization is ST PAUL RHEUMATOLOGY P A (NPI: 1053344788; TIN: 411989447) and primary practice location at 55121-1783. Ridley is affiliated with the Aledade 103 Upper Midwest MSSP (ACO ID: A5003), participating under the MSSP model.

Ridley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 244 traditional Medicare patients, billed 110,006 HCPCS/CPT codes, and received $1,494,308 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,424 prescription claims across 409 beneficiaries totaling $515,483 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 16 records totaling $231,144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	218	59,526	$1,590,736
2016	210	87,596	$2,164,672
2017	205	93,601	$2,077,019
2018	209	93,427	$2,260,096
2019	318	184,314	$4,091,402
2020	308	173,011	$4,677,630
2021	325	171,543	$4,092,645
2022	298	151,063	$2,571,429
2023	269	163,439	$2,469,069
2024	244	110,006	$1,494,308

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	359	1,634	$585,532
2016	400	2,147	$641,868
2017	413	2,108	$637,357
2018	374	2,167	$645,128
2019	388	2,117	$638,581
2020	419	2,654	$652,168
2021	416	2,414	$671,372
2022	438	2,362	$1,036,104
2023	431	2,339	$1,156,803
2024	409	1,424	$515,483

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	203	463	$90
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	154	563	$45
96366	Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	58	230	$15
36415	Insertion of needle into vein for collection of blood sample	153	263	$5
J7050	Infusion, normal saline solution, 250 cc	153	602	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	17	476	$205,226
Enbrel Sureclick	Etanercept	11	308	$84,071
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	266	20,717	$16,044
Methotrexate	Methotrexate Sodium	334	25,014	$13,603
Azathioprine	Azathioprine	163	12,194	$9,205

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$371	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$230,772	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David J. Ridley, M.D.?

Tedicare shows public-source Medicare data for David J. Ridley, M.D. (NPI 1659396000), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David J. Ridley, M.D. have ACO affiliation data?

David J. Ridley, M.D. is shown with ACO affiliation data for Aledade 103 Upper Midwest MSSP (MSSP, ACO ID A5003).

What billing organization is linked to David J. Ridley, M.D.?

David J. Ridley, M.D. is linked to ST PAUL RHEUMATOLOGY P A (billing NPI 1053344788) in the available physician profile data.

Does David J. Ridley, M.D. have Open Payments data?

David J. Ridley, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.